Bizarre Patents
A fork with timer for providing a cue to a user after an elapsed period of time for indicating that another bite of food using the fork may be taken.
PatentStorm News
Make the Most of PatentStorm
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest patents by subscribing to an RSS feed.
Got questions? Ask a Patent Expert!
Registered users: Manage your profile, comments and alerts.
US Patent 6858228 - Solid oral dosage forms of valsartan
US Patent Issued on February 22, 2005
Estimated Patent Expiration Date:
September 20, 2022Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
Estimated Patent Expiration Date:
September 20, 2022Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.AbstractThe present invention is concerned with solid oral dosage forms of comprising a) an active agent selected from valsartan and optionally HCTZ, and b) Pharmaceutically acceptable additives suitable for the preparation of solid oral dosage forms by compression methods.Other References
| InventorsAssigneeApplicationNo. 10251009 filed on 09/20/2002US Classes:424/465, With claimed perfecting feature in contents (e.g., excipient, lubricant, etc.)424/464, Tablets, lozenges, or pills424/489, Particulate form (e.g., powders, granules, beads, microcapsules, and pellets)514/223.5, With additional active ingredient514/223.2, 1,2,4 - Benzothiadiazine - 1,1 - dioxides (including hydrogenated)514/222.8, Polycyclo ring system having the six-membered hetero ring as one of the cyclos514/381, Tetrazoles (including hydrogenated)424/488, Polysaccharides (e.g., cellulose, etc.)514/382Additional chalcogen containing hetero ringField of Search424/465, With claimed perfecting feature in contents (e.g., excipient, lubricant, etc.)424/464, Tablets, lozenges, or pills424/489, Particulate form (e.g., powders, granules, beads, microcapsules, and pellets)514/223.5, With additional active ingredient514/223.2, 1,2,4 - Benzothiadiazine - 1,1 - dioxides (including hydrogenated)514/222.8Polycyclo ring system having the six-membered hetero ring as one of the cyclosExaminersPrimary: Page, Thurman K.Assistant: Di Nola-Baron, Liliana Attorney, Agent or FirmUS Patent References3200039, 4353887, Divisible tablet having controlled and delayed release of the active substanceIssued on: 10/12/1982 Inventor: Hess , et al.5399578, Acyl compounds Issued on: 03/21/1995 Inventor: Buhlmayer, et al.5464854, Method of modifying ovarian hormone-regulated AT1 receptor activity as treatment of incapacitating symptom(s) of P.M.S. Issued on: 11/07/1995 Inventor: dePadova5486364, Readily available konjac glucomannan as a sustained release excipient Issued on: 01/23/1996 Inventor: King, et al.6218414, Use of an angiotensin II antagonist and a benzofuran derivative in the treatment of cardiovascular complaints Issued on: 04/17/2001 Inventor: Nisato6294197, Solid oral dosage forms of valsartan Issued on: 09/25/2001 Inventor: Wagner, et al.6485745Solid oral dosage forms of valsartan Issued on: 11/26/2002 Inventor: Wagner, et al. Foreign Patent References
International ClassA61K009/20 |
